News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
150,931 Results
Type
Article (4844)
Company Profile (85)
Press Release (146000)
Multimedia
Podcasts (5)
Webinars (7)
Section
Business (44725)
Career Advice (210)
Deals (6842)
Drug Delivery (17)
Drug Development (18435)
Employer Resources (19)
FDA (1730)
Job Trends (2906)
News (70893)
Policy (4098)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (326)
Accelerated approval (12)
ADA (15)
Adcomms (1)
Allergies (50)
Alliances (12726)
ALS (74)
Alzheimer's disease (511)
Antibody-drug conjugate (ADC) (176)
Approvals (1873)
Artificial intelligence (150)
ASCO (76)
Autoimmune disease (160)
Automation (16)
Bankruptcy (38)
Best Places to Work (2337)
BIO (49)
BIOSECURE Act (14)
Biosimilars (42)
Biotechnology (77)
Bladder cancer (71)
Brain cancer (16)
Breast cancer (247)
Cancer (1835)
Cardiovascular disease (71)
Career advice (203)
Career pathing (5)
CAR-T (169)
CDC (2)
Celiac Disease (1)
Cell therapy (436)
Cervical cancer (11)
Clinical research (17053)
Collaboration (777)
Compensation (407)
Complete response letters (9)
COVID-19 (479)
CRISPR (31)
C-suite (557)
Cystic fibrosis (49)
Data (2846)
Depression (32)
Dermatology (16)
Diabetes (152)
Diagnostics (908)
Digital health (3)
Diversity, equity & inclusion (8)
Drug discovery (144)
Drug pricing (10)
Drug shortages (3)
Duchenne muscular dystrophy (71)
Earnings (14667)
Editorial (8)
Employer resources (20)
Events (28408)
Executive appointments (453)
FDA (2696)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (19)
Funding (646)
Gene editing (71)
Generative AI (17)
Gene therapy (237)
GLP-1 (199)
Government (399)
Guidances (79)
Healthcare (1874)
Hematology (57)
HIV (15)
Huntington's disease (20)
IgA nephropathy (53)
Immunology and inflammation (85)
Immuno-oncology (32)
Indications (53)
Infectious disease (558)
Inflammatory bowel disease (89)
Inflation Reduction Act (1)
Influenza (45)
Intellectual property (101)
Interviews (19)
IPO (3162)
IRA (4)
Job creations (699)
Job search strategy (185)
JPM (3)
Kidney cancer (3)
Labor market (18)
Layoffs (42)
Leadership (3)
Legal (769)
Liver cancer (19)
Longevity (13)
Lung cancer (190)
Lymphoma (173)
Machine learning (20)
Management (6)
Manufacturing (368)
Marketing (2)
MASH (25)
Medical device (589)
Medtech (598)
Mergers & acquisitions (4124)
Metabolic disorders (328)
mRNA (46)
Multiple sclerosis (78)
NASH (1)
Neurodegenerative disease (139)
Neuropsychiatric disorders (18)
Neuroscience (995)
Neurotech (1)
NextGen: Class of 2026 (895)
Non-profit (284)
Now hiring (7)
Obesity (146)
Opinion (49)
Ovarian cancer (96)
Pain (68)
Pancreatic cancer (107)
Parkinson's disease (163)
Partnered (6)
Patents (184)
Patient recruitment (261)
Peanut (20)
People (18130)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase 1 (6670)
Phase 2 (8143)
Phase 3 (4297)
Pipeline (2940)
Policy (39)
Postmarket research (249)
Preclinical (2863)
Press Release (51)
Prostate cancer (72)
Psychedelics (5)
Radiopharmaceuticals (66)
Rare diseases (268)
Real estate (1565)
Recruiting (10)
Regulatory (4130)
Reports (16)
Research institute (332)
Resumes & cover letters (20)
Rett syndrome (22)
RNA editing (6)
RSV (15)
Schizophrenia (19)
Series A (129)
Series B (90)
Service/supplier (3)
Sickle cell disease (31)
Special edition (3)
Spinal muscular atrophy (44)
Sponsored (6)
Startups (1061)
State (1)
Stomach cancer (2)
Supply chain (29)
Tariffs (10)
The Weekly (5)
Vaccines (170)
Venture capital (28)
Weight loss (58)
Women's health (17)
Worklife (2)
Date
Today (32)
Last 7 days (175)
Last 30 days (745)
Last 365 days (9061)
2026 (4850)
2025 (8825)
2024 (9472)
2023 (10277)
2022 (13453)
2021 (13957)
2020 (10817)
2019 (7294)
2018 (5660)
2017 (6598)
2016 (6018)
2015 (7050)
2014 (5393)
2013 (4438)
2012 (4849)
2011 (5270)
2010 (4845)
Location
Africa (147)
Alabama (59)
Alaska (1)
Arizona (41)
Arkansas (3)
Asia (9645)
Australia (2257)
California (4600)
Canada (1126)
China (417)
Colorado (95)
Connecticut (153)
Delaware (81)
Europe (24304)
Florida (523)
Georgia (72)
Hawaii (2)
Idaho (12)
Illinois (242)
India (27)
Indiana (249)
Iowa (5)
Japan (154)
Kansas (15)
Kentucky (6)
Louisiana (4)
Maine (2)
Maryland (486)
Massachusetts (3601)
Michigan (117)
Minnesota (201)
Mississippi (1)
Missouri (15)
Montana (12)
Nebraska (2)
Nevada (37)
New Hampshire (8)
New Jersey (854)
New Mexico (6)
New York (1057)
North Carolina (541)
North Dakota (5)
Northern California (2363)
Ohio (86)
Oklahoma (7)
Oregon (7)
Pennsylvania (865)
Puerto Rico (13)
Rhode Island (6)
South America (218)
South Carolina (6)
Southern California (1817)
Tennessee (30)
Texas (665)
United States (14772)
Utah (50)
Vermont (1)
Virginia (36)
Washington D.C. (9)
Washington State (601)
West Virginia (1)
Wisconsin (29)
150,931 Results for "immatics biotechnologies gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immatics Announces First Quarter 2026 Financial Results and Business Update
May 12, 2026
·
18 min read
Press Releases
Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting
June 1, 2026
·
9 min read
Press Releases
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
June 1, 2026
·
10 min read
Press Releases
Immatics Announces Full Year 2025 Financial Results and Business Update
March 5, 2026
·
20 min read
Press Releases
PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma
April 20, 2026
·
8 min read
Press Releases
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
April 21, 2026
·
5 min read
Press Releases
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
June 1, 2026
·
11 min read
Press Releases
Immatics Announces $125 Million Underwritten Offering
December 5, 2025
·
3 min read
Press Releases
Immatics Appoints Amie Krause as Chief People Officer
October 27, 2025
·
5 min read
Press Releases
TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH
April 29, 2026
·
5 min read
1 of 15,094
Next
